L-丙氨酰胺盐酸盐 、 乙酰丙酸乙酯 以
水 为溶剂,
以to give the title compound, 4.5 g (19.1%), m.p. 228°-230° C. (with decomposition), [alpha]D =+50.7° (c=3, H2O)的产率得到(3S)-3,7a-dimethyl-2,5-dioxohexahydro-1H-pyrrolo[1,2-a]-imidazole
Condensed imidazole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them.
申请人:ISF SOCIETA PER AZIONI
公开号:EP0335483A3
公开(公告)日:1991-12-18
Compounds of structure (I)
in which, R¹ is hydrogen, C₁₋₄alkyl, CHR⁶CONHR⁷ or CHR⁶COOR⁷ in which R⁶ and R⁷ are each hydrogen or C₁₋₄alkyl; R² is hydrogen, C₁₋₅alkyl or a residue R² of an amino acid R² CH(NH₂)COOH; R³ is hydrogen, C₁₋₄alkyl, CONH₂ or CO₂R⁸ in which R⁸ is hydrogen or C₁₋₄alkyl; and n is 2, 3 or 4, processes for their preparation, intermediates useful in their preparation, pharmaceutical composition containing them and their use in therapy as nootropic agents.
Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines
申请人:I.S.F. Societa per Azioni
公开号:US05130319A1
公开(公告)日:1992-07-14
Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers
A series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones were synthesized. These bicylic derivatives contain both the 2-pyrrolidinone and 4-imidazolidinone nuclei, already recognized as important for cognition enhancing activity. In addition, these structures maintain the backbone of piracetam and oxiracetam with the acetamide side chain restricted in a folded conformation. Their ability to reverse scopolamine-induced amnesia was assessed in a one trial, step-through, passive avoidance paradigm. The main features observed are a potent antiamnestic activity after ip administration (minimal effective dose being between 0.3 and 1 mg/kg ip for most compounds), the presence of a bell-shaped dose-response curve and, generally, a reduction of biological activity after po administration. However, the unsubstituted compound (15, dimiracetam) shows no evidence of a bell-shaped dose-response curve and completely retains activity when given orally, being 10-30 times more potent than the reference drug oxiracetam.
Pinza Mario, Farina Carlo, Cerri Alberto, Pfeiffer Ugo, Riccaboni Maria T+, J. Med. Chem, 36 (1993) N 26, S 4214-4220